IL27 and neoplasm: One possibility is that tumors overexpressing WSX1 compete with immune cells for IL27 and reduce the bioavailability of IL27 to signal into immune cells since IL27 generates anti-tumor activities via signaling through host immune cells [20], [21], [22], [23].